AZoLifeSciences on MSN

Synthetic RNA platform converts viral replication into detectable cellular signals

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Contract Pharma

Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...
Medindia

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...
PharmaTimes

Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies

STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.
Nature

How viral RNAs escape a host mechanism that controls translation

This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
Nanowerk

Engineered RNA sensor detects and fights coronavirus inside living cells

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
eLife

Fragile nucleosomes are essential for RNA Polymerase II to transcribe in eukaryotes

Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...